Rare Occurrence of RHD Null Alleles With Del Expression Among Serologically D-Negative Blood Donors
Abstract
Background/Aim: An investigation into the diversity of serologically D-negative blood donors in the Republic of Srpska entity of Bosnia and Herzegovina forms the basis of this research. The primary purpose of the study was the examination of RHD variants over a period of five years.
Methods: A comprehensive depiction of the RHD distribution in D-negative blood donors is achieved through a combination of serological observations and DNA testing (PCR-SSP with fluorometric signal detection), involving 74,149 blood donors. The adsorption/elution method was used to confirm the Del phenotype.
Results: A small fraction (0.31 %) of the serologically D-negative blood donors was found to contain eight different RHD alleles. The Del phenotype of the RHD*01N.03 and RHD*01EL.44 alleles was highlighted, challenging the common perception that these alleles are associated exclusively with a D-negative expression.
Conclusion: The importance of molecular methods in analysing and understanding Del variants, which typically elude conventional serological assays, is underscored by the findings. A group of donors seemingly having the RHD*01 allele but who lacked D antigen expression was encountered, hinting at the potential presence of still unidentified, possibly geographically restricted, RHD variants or alterations in other genes responsible for the expression of Rh proteins in the erythrocyte membrane.
References
(ISBT 004) RHD blood group alleles v6.4 31-JUL-2023 [Internet]. Amsterdam, The Netherlands: International Society for Blood Transfusion. c2023. [Cited: 17-Jan-2024]. Available from: https://www.isbtweb.org/resource/004rhd.html.
Flegel WA. Molecular genetics and clinical applications for RH. Transfus Apher Sci. 2011;44(1):81-91. doi: 10.1016/j.transci.2010.12.013.
Wagner FF. Considerations on terminology and database organization for blood group genotyping data. Ann Blood. 2023;8:1. doi: 10.21037/aob-21-42.
Wagner FF. Serology and molecular biology of DEL: a narrative review. Ann Blood. 2023;8:28. doi: 10.21037/aob-22-16.
Nuchnoi P, Thongbus J, Srisarin A, Kerdpin U, Prachayasittikul V. Clinical and laboratory update on the DEL variant. Lab Med. 2014;45(4):285-90. doi: 10.1309/LMTUZ00O7VFTGCEB.
Flegel WA, Wagner FF. DEL. Blood Transfus. 2020;18(3):159-62. doi: 10.2450/2020.0296-19.
Scott SA, Nagl L, Tilley L, Liew YW, Condon J, Flower R, et al. The RHD(1227G>A) DEL-associated allele is the most prevalent DEL allele in Australian D- blood donors with C+ and/or E+ phenotypes. Transfusion. 2014;54(11):2931-40. doi: 10.1111/trf.12701.
Sandler SG, Flegel WA, Westhoff CM, Denomme GA, Delaney M, Keller MA, et al. It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. Transfusion. 2015;55(3):680-9. doi: 10.1111/trf.12941.
Kim KH, Kim KE, Woo KS, Han JY, Kim JM, Park KU. Primary anti-D immunization by DEL red blood cells. Korean J Lab Med. 2009;29(4):361-5. doi: 10.3343/kjlm.2009.29.4.361.
Yasuda H, Ohto H, Sakuma S, Ishikawa Y. Secondary anti-D immunization by Del red blood cells. Transfusion. 2005;45(10):1581-4. doi: 10.1111/j.1537-2995.2005.00579.x.
Wagner T, Körmöczi GF, Buchta C, Vadon M, Lanzer G, Mayr WR, et al. Anti-D immunization by DEL red blood cells. Transfusion. 2005;45(4):520-6. doi: 10.1111/j.0041-1132.2005.04256.x.
Shao CP, Wang BY, Ye SH, Zhang WL, Xu H, Zhuang NB, et al. DEL RBC transfusion should be avoided in particular blood recipient in East Asia due to allosensitization and ineffectiveness. J Zhejiang Univ Sci B. 2012;13(11):913-8. doi: 10.1631/jzus.B1100348.
Kim TY, Hong YJ, Kim MJ, Kim H, Kim TS, Park JS, et al. Recommendations Regarding practical DEL typing strategies for serologically D-negative Asian donors. Transfus Med Hemother. 2020;47(1):88-93. doi: 10.1159/000500098.
Wagner FF. RHD PCR of D-Negative blood donors. Transfus Med Hemother. 2013;40(3):172-81. doi: 10.1159/000351604.
Shao CP, Maas JH, Su YQ, Köhler M, Legler TJ. Molecular background of Rh D-positive, D-negative, D(el) and weak D phenotypes in Chinese. Vox Sang. 2002;83(2):156-61. doi: 10.1046/j.1423-0410.2002.00192.x.
Chen JC, Lin TM, Chen YL, Wang YH, Jin YT, Yue CT. RHD 1227A is an important genetic marker for RhD(el) individuals. Am J Clin Pathol. 2004;122(2):193-8. doi: 10.1309/3XMF-2NV5-707T-JE7X.
Kim JY, Kim SY, Kim CA, Yon GS, Park SS. Molecular characterization of D- Korean persons: development of a diagnostic strategy. Transfusion. 2005;45(3):345-52. doi: 10.1111/j.1537-2995.2005.04311.x.
Hong YJ, Kim H, Song EY, Cho D, Park KU, Han KS. Development of real-time PCR and melting curve analysis for the rapid detection of DEL with RHD (c.1222T>C) or RHD (c.1227G>A). Clin Lab. 2016;62(10):1995-2000. doi: 10.7754/Clin.Lab.2016.160320.
Polin H, Danzer M, Gaszner W, Broda D, St-Louis M, Pröll J, et al. Identification of RHD alleles with the potential of anti-D immunization among seemingly D- blood donors in Upper Austria. Transfusion. 2009;49(4):676-81. doi: 10.1111/j.1537-2995.2008.02046.x.
Flegel WA, von Zabern I, Wagner FF. Six years' experience performing RHD genotyping to confirm D- red blood cell units in Germany for preventing anti-D immunizations. Transfusion. 2009;49(3):465-71. doi: 10.1111/j.1537-2995.2008.01975.x.
Guzijan G, Jovanovic Srzentic S, Pavlovic Jankovic N, Djilas I, Lilic M. Implementation of molecular RHD typing at two blood transfusion institutes from southeastern Europe. Transfus Med Hemother. 2019;46(2):114-20. doi: 10.1159/000496751.
Lilić M, Jaklin G, Gojčeta K, Raos M, Golubić Ćepulić B. [Molecular determination of the RHD allele in the population of RhD-negative blood donors in northwestern Croatia]. 8. hrvatski transfuziološki kongres, Zagreb, 4.-7.11.2021. Liječ Vjesn. 2021;143(Supl. 2):52-53. Croatian.
Seo MH, Won EJ, Hong YJ, Chun S, Kwon JR, Choi YS, et al. An effective diagnostic strategy for accurate detection of RhD variants including Asian DEL type in apparently RhD-negative blood donors in Korea. Vox Sang. 2016;111(4):425-30. doi: 10.1111/vox.12450.
Luettringhaus TA, Cho D, Ryang DW, Flegel WA. An easy RHD genotyping strategy for D- East Asian persons applied to Korean blood donors. Transfusion. 2006;46(12):2128-37. doi: 10.1111/j.1537-2995.2006.01042.x.
Orzińska A, Guz K, Polin H, Pelc-Kłopotowska M, Bednarz J, Gieleżyńska A, et al. RHD variants in Polish blood donors routinely typed as D-. Transfusion. 2013;53(11 Suppl 2):2945-53. doi: 10.1111/trf.12230.
Ohto, H, Flegel, WA, Safic Stanic, H. When should RhD-negative recipients be spared the transfusion of DEL red cells to avoid anti-D alloimmunization? Transfusion. 2022;62(11):2405–8. doi: 10.1111/trf.17122.
Wagner FF, Flegel WA. The Rhesus Site. Transfus Med Hemother. 2014;41(5):357-63. doi: 10.1159/000366176.
Safic Stanic H, Kruhonja Galic Z, Dogic V, Bingulac-Popovic J, Jukic I. Serological and molecular characterisation of the most prevalent weak D variants in Croatian population. Transfusion Medicine. 2023;33(2):132-6. doi: 10.1111/tme.12944.
Lukacevic Krstic J, Dajak S, Bingulac-Popovic J, Dogic V, Mratinovic-Mikulandra J. Anti-D reagents should be chosen accordingly to the prevalence of D variants in the obstetric population. J Clin Lab Anal. 2018;32(3):e22285. doi: 10.1002/jcla.22285.
Safic Stanic H, Dogic V, Herceg I, Jagnjic S, Bingulac-Popovic J, Babic I, et al. D variants in the population of D-negative blood donors in the north-eastern region of Croatia. Transfus Med. 2021;31(1):43-7. doi: 10.1111/tme.12726.
Polin H, Danzer M, Hofer K, Gassner W, Gabriel C. Effective molecular RHD typing strategy for blood donations. Transfusion. 2007;47(8):1350-5. doi: 10.1111/j.1537-2995.2007.01278.x.
Koutsouri T, Chaiκali A, Giannopoulos A, Douramani P, Flesiopoulou I, Panos P, et al. Frequency distribution of RHD alleles among Greek donors with weak D phenotypes demonstrates a distinct pattern in central European countries. Transfusion Med. 2019;29:468-70. doi: 10.1111/tme.12623.
Omi T, Takahashi J, Tsudo N, Okuda H, Iwamoto S, Tanaka M, et al. The genomic organization of the partial D category DVa: the presence of a new partial D associated with the DVa phenotype. Biochem Biophys Res Commun. 1999;254(3):786-94. doi: 10.1006/bbrc.1998.0121.
Hyodo H, Ishikawa Y, Kashiwase K, Ogawa A, Watanabe Y, Tsuneyama H, et al. Polymorphisms of RhDVa and a New RhDVa–Like Variant Found in Japanese Individuals. Vox Sanguinis. 2000;78:122-5. doi: 10.1046/j.1423-0410.2000.7820122.x.
Floch A, Téletchéa S, Tournamille C, de Brevern AG, Pirenne F. A Review of the literature organized into a new database: RHeference. Transfus Med Rev. 2021;35(2):70-7. doi: 10.1016/j.tmrv.2021.04.002.
Ye SH, Wu DZ, Wang MN, Wu XY, Xu HG, Xu H, et al. A comprehensive investigation of RHD polymorphisms in the Chinese Han population in Xi'an. Blood Transfus. 2014;12(3):396-404. doi: 10.2450/2013.0121-13.
Daniels G. Rh and RHAG Blood Group Systems. In: Daniels G, editor. Human blood groups. 3rd ed. Chichester, UK: Wiley Blackwell; 2013. p.182-258.
Gowland P, Gassner C, Hustinx H, Stolz M, Gottschalk J, Tissot JD, et al. Molecular RHD screening of RhD negative donors can replace standard serological testing for RhD negative donors. Transfus Apher Sci. 2014;50(2):163-8. doi: 10.1016/j.transci.2014.02.009.
Crottet SL, Henny C, Meyer S, Still F, Stolz M, Gottschalk J, et al. Implementation of a mandatory donor RHD screening in Switzerland. Transfus Apher Sci. 2014;50(2):169-74. doi: 10.1016/j.transci.2014.02.011.
Pereira J, Salvado R, Martins N, Ribeiro ML. RHD null alleles in the Portuguese population. Transfus Med. 2009;19(Suppl. 1):25, PO13.
Li Q, Hou L, Ye LY, Yue DQ, Zhu ZY. Molecular basis of the RHD gene in blood donors with DEL phenotypes in Shanghai. Vox Sang. 2009;97(2):139-46. doi: 10.1111/j.1423-0410.2009.01181.x.
Xu W, Zhu M, Wang BL, Su H, Wang M: Prospective evaluation of a transfusion policy of RhD-positive red blood cells into DEL patients in China. Transfus Med Hemother. 2015;42(1):15-21. doi: 10.1159/000370217.
Ye L, Yue D, Wo D, Ding X, Guo S, Li Q, Guo Z, Zhu Z. Molecular bases of unexpressed RHD alleles in Chinese D− persons. Transfusion. 2009;49(8):1655-60. doi: 10.1111/j.1537-2995.2009.02181.x.
Kulkarni SS, Gogri H, Parchure D, Mishra G, Ghosh K, Rajadhyaksha S, et al. RHD-positive alleles among D- C/E+ individuals from India. Transfus Med Hemother. 2018;45(3):173-7. doi: 10.1159/000479239.
Trucco Boggione C, Nogués N, González-Santesteban C, Mufarrege N, Luján Brajovich M, Mattaloni SM, et al. Characterization of RHD locus polymorphism in D negative and D variant donors from Northwestern Argentina. Transfusion. 2019;59(10):3236-42. doi: 10.1111/trf.15504.
Thongbut J, Laengsri V, Raud L, Promwong C, I-Na-Ayudhya C, Férec C, et al. Nation-wide investigation of RHD variants in Thai blood donors: Impact for molecular diagnostics. Transfusion. 2021;61(3):931-8. doi: 10.1111/trf.16242.
Srivastava K, Bueno MU, Flegel WA. Breakpoint regions of an RHD-CE(4-9)-D allele and a rare JK allele in a Pacific Islander individual. Blood Transfus. 2023 Aug 25. doi: 10.2450/BloodTransfus.534.
Thongbut J, Raud L, Férec C, Promwong C, Nuchnoi P, Fichou Y. Comprehensive molecular analysis of serologically D-negative and weak/partial D phenotype in Thai blood donors. Transfus Med Hemother. 2020;47(1):54-60. doi: 10.1159/000499087.
Daniels G. An overview of blood group genotyping. Ann Blood. 2023;8:3. doi: 10.21037/aob-21-37.
Wen J, Verhagen OJHM, Jia S, Liang Q, Wang Z, Wei L, et al. A variant RhAG protein encoded by the RHAG*572A allele causes serological weak D expression while maintaining normal RhCE phenotypes. Transfusion. 2019;59(1):405-11. doi: 10.1111/trf.14969.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).